These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9397232)

  • 21. Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators.
    Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe JH; Hartzler GO; Overlie P; Donohue B; Chelliah N; Vlietstra R; Puchrowicz-Ochocki S; O'Neill WW
    Cathet Cardiovasc Diagn; 1996 Dec; 39(4):333-9. PubMed ID: 8958418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial infarction in the elderly: benefits and risks of thrombolytics.
    Aronow WS
    Drug Saf; 2002; 25(11):753-8. PubMed ID: 12222987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical trials in thrombolytic therapy, Part 1: Outcome markers that go beyond mortality reduction.
    Stringer KA
    Am J Health Syst Pharm; 1997 Nov; 54 Suppl 1():S23-6. PubMed ID: 9397234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracranial hemorrhage rates and effect of immediate beta-blocker use in patients with acute myocardial infarction treated with tissue plasminogen activator. Participants in the National Registry of Myocardial Infarction-2.
    Barron HV; Rundle AC; Gore JM; Gurwitz JH; Penney J
    Am J Cardiol; 2000 Feb; 85(3):294-8. PubMed ID: 11078295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newer thrombolytic drugs for acute myocardial infarction.
    Reddy DS
    Indian J Exp Biol; 1998 Jan; 36(1):1-15. PubMed ID: 9536645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reteplase: new preparation. Minimal value: bolus versus infusion.
    Prescrire Int; 1998 Jun; 7(35):73-4. PubMed ID: 10342921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thrombolytic therapy of acute myocardial infarction].
    Verstraete M
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1883-9. PubMed ID: 8729370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anaphylactoid reaction during administration of tissue plasminogen activator (t-PA)].
    Cannas S; De Leo A; Marzari A
    G Ital Cardiol; 1997 Mar; 27(3):278-80. PubMed ID: 9244730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical and pharmacologic comparison of thrombolytic agents.
    Stringer KA
    Pharmacotherapy; 1996; 16(5 Pt 2):119S-126S. PubMed ID: 8888099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction.
    Katus HA; Remppis A; Scheffold T; Diederich KW; Kuebler W
    Am J Cardiol; 1991 Jun; 67(16):1360-7. PubMed ID: 1904190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thrombolytic treatment of acute myocardial infarct. 1].
    Soares-Costa JT; Soares-Costa TJ; Gabriel HM
    Acta Med Port; 1998 May; 11(5):409-19. PubMed ID: 9951051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombolytic therapy for acute stroke in a teenager.
    Muñiz AE
    Pediatr Emerg Care; 2012 Feb; 28(2):170-3. PubMed ID: 22307187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombolytic therapy.
    Goldhaber SZ
    Adv Intern Med; 1999; 44():311-25. PubMed ID: 9929714
    [No Abstract]   [Full Text] [Related]  

  • 34. Procoagulant effects of thrombolytic therapy in acute myocardial infarction.
    Wang Y; Liu Q; Zhu J; Yuan Z; Ma X
    Chin Med Sci J; 2002 Mar; 17(1):36-9. PubMed ID: 12894883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The need for wider utilization of thrombolytic therapy.
    Hennekens C
    Clin Cardiol; 1997 Nov; 20(11 Suppl 3):III26-31. PubMed ID: 9422860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guidelines for the use of intravenous thrombolytic agents in acute myocardial infarction. Ontario Medical Association Consensus Group on Thrombolytic Therapy.
    Naylor CD; Armstrong PW
    CMAJ; 1989 Jun; 140(11):1289-99. PubMed ID: 2497946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraventricular bleeding after the use of thrombolytics in a cocaine user.
    LoVecchio F; Nelson L
    Am J Emerg Med; 1996 Nov; 14(7):663-4. PubMed ID: 8906766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.
    Evrengul H; Celek T; Tanriverdi H; Kaftan A; Dursunoglu D; Kilic M
    Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biochemical, pharmacologic and clinical properties of new thrombolytic agents].
    Gulba DC
    Internist (Berl); 1996 Jun; 37(6):552-66. PubMed ID: 8767988
    [No Abstract]   [Full Text] [Related]  

  • 40. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.